MoviPrep: Clinical Trials

8 trials of MoviPrep, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 completed. 8 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 38Completed 8
Phase 21Completed 1

Follow MoviPrep: new trials by email Literature Review of MoviPrep trials Research Report on MoviPrep

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of mAnnitol in Bowel Preparation During Elective Colonoscopy and Comparison With Moviprep®
Phase II: NTC015 low dose, Phase II: NTC015 medium dose, Phase II: NTC015 high dose - Elective Colonoscopy
Phase 2 / Phase 3CompletedNTC srl8862020-06-182025-12-08
Safety and Efficacy of CDFR0612 and CDFR0613 for Bowel Cleansing Before Colonoscopy
CDFR0612, CDFR0613, Coolprep Powder - Colonoscopy Preparation, Colon Disease
Phase 3CompletedCTC Bio, Inc.3102015-01-012015-09-11
Improvement of Tolerance of Bowel Cleansing Before Colonoscopy in Diabetic Patients
PEG-ascorbate 2L, PEG 4L - Diabetes Mellitus, Colonic Diseases
Phase 3CompletedParc de Salut Mar1582014-12-022017-02-23
Multicenter Randomized Parallel Group Phase III Study Comparing the Bowel Cleansing Efficacy, Safety and Tolerability of NER1006 Versus MOVIPREP® Using 2-Day Split-Dosing and 1-Day Morning Split-Dosing Regimen in Adults.
NER1006, 2-Day Split-Dosing, NER1006,1-Day Morning Split-Dosing, MOVIPREP, 2-Day Split-Dosing - Colorectal Cancer, Colorectal Carcinoma
Phase 3CompletedNorgine8492014-10-012018-05-15
Evaluation of the Efficacy, Safety and Tolerance of Experimental Morning-only MOVIPREP® Bowel Preparation in Comparison With Split-dose With Nocturnal Pause MOVIPREP® Bowel Preparation
MOVIPREP - Bowel Preparation Prior to Endoscopic, Radiological and Other Examinations as Well as to Surgical Procedures Which Require Empty Bowel.
Phase 3CompletedTakeda1402012-11-012014-05-15
Comparison of 2L NRL994 With NaP Preparation in Colon Cleansing Prior to Colonoscopies for Colon Tumor Screening
Macrogol 3350 Na sulphate NaCl KCl Ascorbic Acid Na Ascorbate, Sodium Phosphate solution (NaP) - Colonoscopy
Phase 3CompletedNorgine3602004-09-012008-04-16
A Phase III Trial to Assess the Efficacy, Acceptability and Safety of Moviprep® Versus a 4L PEG+E Standard Solution
Macrogol3350 NA sulphate NACl KCl ascorbic acid NA ascorbate, Macrogol3350 Na sulphate Na bicarbonate NaCl KCl - Colonoscopy
Phase 3CompletedNorgine3602002-06-012008-04-16
MOVIPREP® Versus NaP Pivotal Phase III Study
macrogol3350 NA sulphate NACL KCL ascorbic acid NA ascorbate, Sodium Phosphate Solution - Colonoscopy
Phase 3CompletedNorgine3402002-04-012008-04-16

Conditions studied

Colonic Diseases (2)  ·  Colorectal Neoplasms (1)  ·  Diabetes Mellitus (1)  ·  Mucopolysaccharidosis IV (1)  ·  Personal Satisfaction (1)

Sponsors

Norgine (4)  ·  CTC Bio, Inc. (1)  ·  NTC srl (1)  ·  Parc de Salut Mar (1)  ·  Takeda (1)

Countries

Germany (4)  ·  France (3)  ·  Italy (2)  ·  Russia (2)  ·  Spain (2)  ·  Belgium (1)  ·  Kazakhstan (1)  ·  Poland (1)  ·  South Korea (1)  ·  United Kingdom (1)

Top investigators

Christian Ell, Prof Dr med (2)  ·  Alain Bitoun, MD (1)  ·  Dongjin Yoo, M.D. (1)  ·  Gianpiero Manes, Dr. (1)  ·  Raf Bisschops, MD (1)

Results publications

PMID 18190651, PMID 25180609, PMID 30025414, PMID 36064325, PMID 36799346, PMID 40786127

NIH funding

2019 (1)